Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

DOI Full Paper Access

239

Citations

27

References

2019

Year

Magdy Selim, Lydia D. Foster, Claudia S. Moy, Guohua Xi, Michael D. Hill, Lewis B. Morgenstern, Steven M. Greenberg, Michael L. James, Vineeta Singh, Wayne M. Clark,

The Lancet Neurology

ThrombosisReperfusion InjuryDeferoxamine MesylateMedicineHemostasisBrain InjuryNeurologyIntracerebral HaemorrhageCerebral Blood FlowNeuropathologyStrokeBleeding DisorderAnesthesiologyDouble-blind Phase 2

References

	Year	Citations

Page 1

Page 1